•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Natera, Inc. $NTRA Stock Sold by Eurizon Capital SGR S.p.A.
Natera CFO Maps Multiple Paths to $6 Billion Revenue Target by 2029
Natera CFO Defends CEO Switch, Calls $6 Billion Revenue Target a “Way Station”
Natera, Inc. (NTRA) Presents at 2026 UBS Global Healthcare Conference Transcript
Natera, Inc. (NTRA) Presents at 8th Annual Wolfe Research Healthcare Conference Transcript
Natera Announces Clinical Collaboration with Incyte on Interventional Phase II Study in Colorectal Cancer
Natera Q3 Earnings Call Highlights $6B Target & Raised 2026 Outlook
NTRA Q3 Loss Wider Than Expected, Revenues Beat, '26 Sales View Up
Natera, Inc. $NTRA Stock Holdings Lessened by Candriam S.C.A.
Natera (NASDAQ:NTRA) Insider Sells $1,401,003.63 in Stock
Natera (NASDAQ:NTRA) Insider Sells $1,401,003.63 in Stock
Natera (NASDAQ:NTRA) CEO Sells $1,565,251.80 in Stock
Natera, Inc. (NTRA) Q3 2026 Earnings Call Transcript
Natera Stock Plummets After Mixed Q3 Financials
What Natera (NTRA) Said on Its Q3 Earnings Call
Allspring Growth Fund Q3 2026 Performers And Detractors
Alger Concentrated Equity ETF Q3 2026 Portfolio Update
Natera Announces Leadership Transition
Natera Reports Third Quarter 2026 Financial Results
Signatera™ Monitoring During First-Line Immunotherapy Showed ctDNA Clearance is Associated with Long-Term Survival Across Four Metastatic Cancers